Alan B. Lancz & Associates, Inc. Sanofi Transaction History
Alan B. Lancz & Associates, Inc.
- $98.1 Million
- Q2 2025
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Sanofi stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 5,250 shares of SNY stock, worth $260,714. This represents 0.26% of its overall portfolio holdings.
Number of Shares
5,250
Previous 5,250
-0.0%
Holding current value
$260,714
Previous $291,000
13.06%
% of portfolio
0.26%
Previous 0.31%
Shares
10 transactions
Others Institutions Holding SNY
# of Institutions
828Shares Held
260MCall Options Held
1.75MPut Options Held
1.6M-
Dodge & Cox San Francisco, CA71.7MShares$3.56 Billion2.09% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.1MShares$652 Million0.26% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$502 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC10MShares$497 Million0.04% of portfolio
-
Invesco Ltd. Atlanta, GA9.19MShares$456 Million0.08% of portfolio
About Sanofi
- Ticker SNY
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,508,100,096
- Market Cap $125B
- Description
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...